Healthcare >> Sector Roundtables >> December 13, 2004


Kalia, Suraj
SURAJ KALIA joined Northland Securities, Inc., in March 2003 and follows life sciences and technology companies. Prior to Northland, Mr. Kalia worked in the Business Development Group at Entegris, Inc., where he was responsible for analyzing potential acquisition targets, strategic and financial valuation, due diligence, deal structuring and management interviews. Prior to moving to Minneapolis to join Entegris, he worked as an analyst at a boutique broker-dealer in New Jersey, where he wrote and modeled numerous companies in the healthcare sector. Prior to moving to the US, he worked for 4 years in India at Tata Capital as an Investment Banking Analyst. Mr. Kalia has over 10 years of work experience in equity research, M&A and engineering. He holds a Bachelor's degree in Chemical Engineering from the prestigious Indian Institute of Technology in Bombay, India. He received his Master's degree in Chemical Engineering at Stevens Institute of Technology, New Jersey and his MBA from the University of St. Thomas, Minneapolis, where he currently serves an Adjunct Professor of Finance for the MBA curriculum. He is a member of the Twin Cities Society of Security Analysts and the Association for Investment Management and Research (AIMR) and adheres to AIMR's Code of Ethics and Standards of Professional Conduct as a charterholder of the Chartered Financial Analyst designation. Profile
ELI KAMMERMAN covers the medical devices industry as a Senior Analyst at Cathay Financial LLC. He began following the industry in 1994, after following the biotechnology sector for two years. As an Analyst, Mr. Kammerman has worked at Merrill Lynch, Salomon Brothers, and Raymond James. He was employed for 11 years in the biotech, diagnostics and pharmaceutical industries in production and marketing positions. Mr. Kammerman holds a BA in Biology from Boston University and attended the Technology Management program at the University of Maryland. Profile
ANTHONY V. VENDETTI has been a Senior Healthcare Analyst on Wall Street for more than 10 years and follows the medical device, healthcare information technology and services industries. Prior to joining Maxim Group, LLC, Mr. Vendetti was a Senior Healthcare Analyst at Gruntal, UBS Securities and Ladenburg Thalmann. Mr. Vendetti also worked for three years in the healthcare industry at CIGNA, ultimately as a Senior Healthcare Analyst in the managed care division. His responsibilities at CIGNA included industry research, forecasting healthcare expenditures, writing analytical narratives of clients' medical benefit plans, and identifying cost containment measures. Mr. Vendetti earned his MBA in Finance and Accounting at Rensselaer Polytechnic Institute, and his BS degree in Biology at SUNY Binghamton. While at Binghamton, Mr. Vendetti was pre-med, earned his emergency medical technician certification and was a member of the Binghamton volunteer ambulance corps. He is also a member of the Association for Investment Management and Research and the Healthcare Information and Management Systems Society. Mr. Vendetti has been a guest speaker on CNNfn, CNN MoneyLine, and a member of investment panels at various healthcare conferences nationwide. In addition, he has been quoted in numerous healthcare journals and financial publications such as BusinessWeek, Investors Business Daily and The Wall Street Journal. On June 26, 2001, The Wall Street Journal ranked Mr. Vendetti as one of the best stock-picking analysts in its annual 2000 Best on the Street survey.. Profile
TWST: Anthony, please give us an overview of Maxim Group.

Mr. Vendetti: Maxim Group is a full-service investment bank broker-

dealer, and we specialize in small to mid-cap healthcare and